StephenLouisWeinribMD

Endocrinology • Asheville, NC

Diabetes, Lipid Metabolism, Thyroid

MAHEC, endocrine faculty

Join to view full profile

Dr. Weinrib is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weinrib's full profile

Already have an account?

Office
123 Hendersonville Rd
Asheville, NC 28803
Phone+1 828-771-3500

Fax+1 828-412-4171

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1997
Lahey ClinicFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1996
George Washington UniversityResidency, Internal Medicine, 1992 - 1995
University of Alabama School of MedicineClass of 1992

Certifications & Licensure

NC State Medical License 2002 - 2025
AL State Medical License 1997 - 2002
MA State Medical License 1996 - 1998
National Board of Physicians and Surgeons Endocrinology Diabetes and Metabolism

Publications & Presentations

PubMed

18 citations
The effect of long-term use of U-500 insulin via continuous subcutaneous infusion on durability of glycemic control and weight in obese, insulin-resistant patients wit...
Wendy Lane, Stephen L. Weinrib, Jonathan M. Rappaport, Christopher B. Hale, Lynley K. Farmer
Endocrine Practice. 2013-03-01
3 citations
Basal Insulin degludec and GLycemic control ComparEd to Aspart via insulin Pump in type 1 diabetes (BIGLEAP): a single-center, open-label, randomized, crossover trial.
Wendy Lane, Stephen L. Weinrib, Michael J. Lawrence, Benjamin C. Lane, Ryan T. Jarrett
Endocrine Practice. 2021-11-08
32 citations
A PROSPECTIVE TRIAL OF U500 INSULIN DELIVERED BY OMNIPOD IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SEVERE INSULIN RESISTANCE
Wendy Lane, Stephen L. Weinrib, Jonathan M. Rappaport, Therese Przestrzelski
Endocrine Practice. 2010-09-01

Lectures

Liraglutide Added to High-Dose Basal/Bolus Insulin in Type 2 Diabetes
Asheville, NC - 6/15/2014

Press Mentions

Asheville Area Doctors Work Through Challenges to Serve PatientsOctober 4th, 2024